Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Northern Star exceeds FY18 guidance

2018-07-18 businessnews.com.au
Northern Star Resources has reported above-guidance gold production for the year to June, with plans to expand output beyond 600,000 ounces in 2019, while Blackham Resources posted improved results for the half-year to June.
BKHRF NST BLK NHRNY NESRF

0
Blackham Resources achieves record half-year gold production at Matilda‐Wiluna

2018-07-18 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) has achieved record gold production of 40,024 ounces for the six months to June 2018 at its Matilda‐Wiluna Gold Operation in Western Australia, a 31% increase on the last half.
BKHRF BLK

0
Gateway Mining’s 24.2 g/t of gold over 4 metres reveals potential new discovery at Gidgee project

2018-07-10 proactiveinvestors.com.au
Gateway Mining Ltd (ASX:GML) believes a 4-metre intersection grading 24.2 g/t gold from 241 metres indicates the potential for a new high-grade discovery at the Gidgee Gold Project in Western Australia.
GML BKHRF RMS BLK RMLRF

3
Renegade Exploration continues major drill program at Yandal East Gold Project

2018-06-26 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) has completed drilling at the Coralie Jean prospect within its Yandal East Gold Project in Western Australia.
EAR BKHRF NSR SCEXF NST BLK NHRNY SAR NESRF

1
Blackham Resources bolsters Board with appointment of experienced mining engineer

2018-06-22 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) has strengthened its Board with the appointment of experienced mining engineer Tony James as a non-executive director.
AQG ALIAF CRNRF BKHRF ASR DRM BLK ALACF CRB

0
Blackham Resources’ drilling extends high-grade free-milling mineralisation at Wiluna Mine

2018-06-21 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) has revealed high-grade drilling results from the Wiluna Gold Project in Western Australia.
BKHRF BLK

0
Blackham Resources reveals potential to extend gold mining area at Golden Age

2018-06-12 proactiveinvestors.com.au
Blackham Resources Ltd’s (ASX:BLK) drilling has extended the mineralisation beyond current mining areas at the high-grade Golden Age orebody at the Wiluna Gold Project in Western Australia.
BKHRF BLK

0
Price of gold spurs wave of WA FIFO jobs in remote mining town of Wiluna

2018-06-11 perthnow.com.au
RISING gold prices look set to bring about a wave of new jobs for FIFO workers - turning a WA ghost town into a boom town in the process.
BKHRF BLK

3
Renegade Exploration trades higher as activity heats up in the Yandal Greenstone Belt

2018-06-07 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) continues to attract investors as the company's exploration plans in the world-class Yandal Greenstone Belt advance.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration revs up for major drilling program in premier gold country

2018-05-21 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) will get the drill bit spinning in early June targeting gold at its Yandal East project in the gold-rich Yandal Greenstone Belt of Western Australia.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration leveraged to gold news flow from world-class Yandal Greenstone Belt

2018-05-10 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) is focused on finding another major gold project in the elephant country that is the Yandal Greenstone Belt near Wiluna in Western Australia’s North Eastern Goldfields.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

0
Blackham Resources drill results reveal potential for new open pits

2018-05-08 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) has received drill results that have identified potential for new open pits close to the plant at the Matilda-Wiluna Gold Project in Western Australia.
BKHRF BLK

0
Blackham Resources finds more effective processing option for Wiluna transitional gold ores

2018-05-02 proactiveinvestors.com.au
Blackham Resources Ltd’s (ASX:BLK) tests have confirmed that transitional ores from the Matilda-Wiluna Gold Project can be processed through the existing CIL plant at a lower cost and improved recovery rate.
BKHRF BLK

0
Blackham Resources’ partner confirms nearby potash potential

2018-04-26 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) recently entered a memorandum of understanding (MoU) with Salt Lake Potash (ASX:SO4) to investigate a sulphate of potash opportunity.
BKHRF SO4 SO4 WHELF BLK

0
Blackham Resources delivers strong production growth and reaffirms June half year guidance

2018-04-16 proactiveinvestors.com.au
Blackham Resources Ltd (ASX:BLK) has delivered quarter-on-quarter production growth of 38% for the March quarter at its Matilda-Wiluna gold operation in Western Australia.
BKHRF BLK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...